MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. AGL
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

agilon health (AGL) Stock Fundamentals, Analysis & Risk Signals

Health score, competitive moat, risk signals, and key metrics at a glance.

NYSE•Healthcare•Medical Care Facilities
C
AverageMetricSide Score: 41/100
ProfitabilityProfit11/25
GrowthGrowth8/25
Balance Sheet & Red FlagsBalance18/25
Cash & Earnings QualityCash4/25

Strongest: Balance Sheet & Red Flags (18/25); weakest: Cash & Earnings Quality (4/25).

Price & Volume
Market Cap $1.56B

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.

Moat Signals

Competitive analysis based on 21 quarters of fundamental data

Pricing Power

Weak Moat

Operating margins are under pressure, averaging -6.3%. The business may lack pricing power or face rising costs.'

Competitive Advantage

Weak Moat

ROE is low or negative, suggesting limited competitive advantage or capital allocation challenges.

Risk Signals

Data-driven red flags and warnings across 21 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 6 of the last 8 quarters — earnings are not translating to cash.

Leverage Risk

Watch

Debt-to-equity has risen 108.0% recently — increasing financial risk even if the current ratio is manageable.

Revenue Decline

Healthy

Revenue is stable or growing over recent quarters — demand appears durable.

Cash Burn

Red Flag

The last 4 consecutive quarters had negative FCF — the company is burning cash and may need external funding.

Share Dilution

Healthy

Share count is stable — no significant dilution or buyback activity.

Metrics at a Glance

as of March 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue
$5.82B
3%
Q. Revenue
$1.42B
7%
TTM EBITDA
$-408.62M
45%
TTM Op. Income
$-437.13M
42%
Q. Op. Income
$4.00M
118%
TTM Net Income
$-354.54M
47%
Q. Net Income
$48.92M
304%
EPS
$2.95
Shares Out.
$16.60M
7Q
$5.82B in TTM revenue declined 2.8% YoY, reaching $1.42B last quarter. TTM EBITDA of $-408.62M and TTM operating income of $-437.13M shows growth is flowing through. However, net income is negative at $354.54M — growth is not yet reaching the bottom line. Revenue is contracting — assess whether this is cyclical or structural. Over the past year, TTM revenue is down 3% — a deteriorating trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin
0.8%
176%
Op. Margin
0.3%
120%
Net Margin
3.4%
336%
Op. margin of 0.3% is up 1.7% YoY — cost efficiency is improving. Net margin at 3.4%. Over the past year, Operating margin is up 120% — a improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio
N/A
P/S Ratio
0.3x
10%
P/B Ratio
8.6x
2Q
P/S of 0.3x and P/B of 8.6x. A low P/S may indicate the stock is undervalued.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets
$1.50B
22%
Cash
$139.99M
2%
Long-Term Debt
$15.28M
2Q
Book Value
$181.43M
64%
D/E Ratio
0.1
108%
Debt/EBITDA
1.4
With $1.50B in assets and $15.28M in long-term debt, the D/E of 0.1and book value of $181.43M — shows a conservative capital structure — the company has a strong financial cushion to weather downturns. Over the past year, Debt/equity is up 108% — a improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$23.73M
174%
TTM Free Cash Flow
$-62.54M
12%
FCF Margin
-1.1%
15%
FCF / Net Income
0.2
24%
TTM FCF of $-62.54M on $23.73M in operating cash flow. The FCF / Net Income ratio of 0.2x indicates partial cash conversion — earnings quality needs attention. Over the past year, Free cash flow is down 12% — a improving trend.

Related Stocks in Healthcare

View Sector
NVDA$4.57T
Nvidia
Semiconductors
GOOG$3.96T
Alphabet Inc. (Class C)
Internet Content & Information
AAPL$3.67T
Apple Inc.
Consumer Electronics
GOOGL$3.66T
Alphabet Inc. (Class A)
Internet Content & Information
MSFT$3.46T
Microsoft
Software - Infrastructure
AMZN$2.56T
Amazon
Internet Retail
META$1.66T
Meta Platforms
Internet Content & Information
AVGO$1.63T
Broadcom
Semiconductors

Cash Generation

Weak Moat

Only 2 of the last 8 quarters had positive FCF — the business may require external capital to sustain operations.

Demand Durability

Moderate Moat

Revenue has grown modestly overall (~13.7%) but trajectory is uneven, suggesting a competitive or cyclical business.